No Role for Reintroducing OPV into the United States with Respect to Controlling COVID-19 [Response to the letter to the Editor by Chumakov et al.]

Risk Anal. 2021 Feb;41(2):389-392. doi: 10.1111/risa.13671.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • SARS-CoV-2
  • United States